​Copyright
© 2014 - 2022

ReMedDev® is a TM of

Vermilion Life Sciences Ltd

COMPANY NUMBER

​​​​ReMedDev Publications

In conjunction with ABPI a Reengineering Medicines Development discussion document was authored. Please click the first image to download the document.

A​ stakeholder roundtable to discuss and define partnership possibilities was jointly hosted with ABPI on 4th March 2015. Please click the second image to download the summary output report.

The joint press releases with ABPI on the launch of the roundtable is here and the report is here. 

The principles of ReMedDev® are visible within the Accelerated Access Review final report

Articles in Scrip and KPMG's Focus on Life Sciences (Page 14) are available via the images below

 ​